Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-22
Closed -$1K 448
2018
Q3
$1K Buy
+22
New +$847 ﹤0.01% 494
2017
Q1
Sell
-2,108
Closed -$65K 291
2016
Q4
$65K Sell
2,108
-20,553
-91% -$627K ﹤0.01% 234
2016
Q3
$728K Sell
22,661
-94,608
-81% -$3.16M 0.04% 164
2016
Q2
$3.92M Buy
+117,269
New +$3.74M 0.24% 54
2016
Q1
Sell
-5,797
Closed -$166K 336
2015
Q4
$178K Buy
+5,797
New +$182K 0.01% 265
2015
Q2
Sell
-16,578
Closed -$547K 509
2015
Q1
$547K Buy
+16,578
New +$527K 0.05% 216
2013
Q3
Sell
-159,699
Closed -$4.24M 266
2013
Q2
$4.24M Buy
+159,699
New +$4.41M 0.43% 44

Other funds holding PFE

Cowen Inc's PFE Position: Q4 2018 in Review

Cowen Inc sold out of Pfizer (PFE) in Q4 2018, closing a stake of 22 shares — an estimated $1K sold.

Cowen Inc first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $4.24M in Q2 2013. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Cowen Inc reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Cowen Inc sold 22 Pfizer shares in Q4 2018, an estimated $1K.
  • Cowen Inc first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
  • Cowen Inc's Pfizer position peaked at $4.24M in Q2 2013.
  • 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Cowen Inc's 13F filing for Q4 2018, filed 14 Feb 2019.